Efficacy of Modified SiShenJian Decoction on Acute Phase of Rheumatoid Arthritis: a Randomized Controlled Trial

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800019157

Enrollment

Unknown

Registered

2018-10-28

Start date

2018-11-01

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

The treatment group:DMARDs+Modified SiShenJian Decoction

The control group:DMARDs

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients will be excluded if they were pregnant women or nursing mothers, have mental illness, comorbid serious disease of the cardiovascular, respiratory, digestive, nervous, urinary and hematopoietic system, used other drugs related to the treatment of RA, and have allergic disease.

Exclusion criteria

Exclusion criteria: We will exclude pregnant and lactating women; psychiatric patients; those with serious heart, liver, kidney function and hematopoietic system; those who have used other treatments; allergic or allergic to multiple drugs.

Design outcomes

Primary

Measure	Time frame
Blood routine;Urine routine;TCM symptoms scores;1987 ACR against Rheumatism Criteria for Classification of Rheumatoid Arthritis;2009 ACR/ EULAR for Classification of Rheumatoid;DAS28;	—

Secondary

Measure	Time frame
SDAI;HAQ;ESR;CRP;	—

Countries

China

Contacts

Public ContactWu bin

Chongqing Hospital of Traditional Chinese Medicine

wuubinn@126.com+86 15086705783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026